Survival outcomes and predictors of mortality, re-bleeding and complications for acute severe variceal bleeding requiring balloon tamponade

Table 2 Management of index variceal bleed and characteristics around insertion of Sengstaken-Blakemore tube

Variable	Value (n = 80)
Vasoactive agent	79 (98.8)
Terlipressin	30 (37.5)
Octreotide	49 (61.3
Empiric antibiotics	77 (96.3)
Time to endoscopy from bleed, h	6.8 (4.2, 19.0)
Site of variceal bleed
Oesophageal varices	64 (80.0)
Gastric varices	16 (20.0)
Initial endoscopic therapy
Variceal band ligation	43 (53.8)
Cyanoacrylate injection	2 (2.5)
Indication for SBT insertion
Incomplete haemostasis	54 (67.5)
Poor endoscopic views	41 (51.2)
Approach for SBT insertion (n = 71)
Nasal	22 (31.0)
Oral	49 (69.0)
Confirmation of SBT position
X-ray	44 (55.0)
Direct endoscopic vision	18 (22.5)
No documentation	15 (18.8)
Gastric balloon inflation (n = 76)
Volume, mL	285 (250, 300)
Time inflated, h	26.8 (16.9, 44.7)
Oesophageal balloon inflation (n = 22)
Volume, mL	100 (39, 100)
Time inflated, h	20.5 (10.2, 36.8)
Therapy post-SBT deflation (n = 62)
Repeat endoscopic therapy	27 (43.5)
Further balloon tamponade	16 (20.0)

Categorical variables presented as number, (percentage) and continuous variables as median, (interquartile range). SBT: Sengstaken-Blakemore tube.